文献速递白血病

PHF6与DNMT3A突变富集于伴T系分化的不同亚组混合表型急性白血病

PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation.
PubMed 文献 · Blood Adv · 2018-01-01

研究对纪念斯隆-凯特琳癌症中心的52例疑似MPAL进行临床病理与遗传学评估,其中29例符合2016年WHO分类的确诊MPAL。PHF6与DNMT3A突变各见于6/26例(23%),两者互斥且与BCR-ABL1/MLL易位互斥,均显著倾向于T系分化。PHF6突变患者较DNMT3A突变者更年轻(中位年龄27岁 vs 61岁,P<.01)。伴T系分化的MPAL与淋巴结或髓外受累(9/15[60%] vs 0,P=.001)及更高复发率(78% vs 22%,P=.017)相关。

要点

  • PHF6与DNMT3A突变各见于6/26例(23%)MPAL,两者互斥且与BCR-ABL1/MLL易位互斥。
  • PHF6突变MPAL中位年龄27岁,DNMT3A突变MPAL中位年龄61岁(P<.01)。
  • 伴T系分化MPAL的淋巴结或髓外受累为9/15(60%)vs 0(P=.001),复发率78% vs 22%(P=.017)。

核心结论

  • PHF6与DNMT3A突变是MPAL中最常见的体细胞改变,似乎定义了伴T系分化且结局较差的两个不同MPAL亚组。

研究设计与样本

  • 对纪念斯隆-凯特琳癌症中心的52例疑似MPAL病例进行临床病理与遗传学评估。
  • 52例中仅29例(56%)符合2016年世界卫生组织分类的确诊MPAL。

主要发现

  • PHF6与DNMT3A突变各见于6/26例(23%)MPAL,两者互斥且与BCR-ABL1/MLL易位互斥。
  • PHF6突变MPAL中5/6例、DNMT3A突变MPAL中6/6例呈现T系分化。
  • PHF6突变MPAL患者较DNMT3A突变者更年轻(中位年龄27岁 vs 61岁,P<.01)。
  • 3例同时伴T系与B系分化的MPAL均携带PHF6突变。
  • 伴T系分化MPAL的淋巴结或髓外受累为9/15(60%)vs 0(P=.001),复发率为78% vs 22%(P=.017)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The genetic aberrations that drive mixed phenotype acute leukemia (MPAL) remain largely unknown, with the exception of a small subset of MPALs harboring BCR -ABL1 and MLL translocations. We performed clinicopathologic and genetic evaluation of 52 presumptive MPAL cases at Memorial Sloan Kettering Cancer Center. Only 29 out of 52 (56%) cases were confirmed to be bona fide MPAL according to the 2016 World Heath Organization classification. We identified PHF6 and DNMT3A mutations as the most common recurrent mutations in MPAL, each occurring in 6 out of 26 (23%) cases. These mutations are mutually exclusive of each other and BCR-ABL1/MLL translocations. PHF6- and DNMT3A-mutated MPAL showed marked predilection for T-lineage differentiation (5/6 PHF6 mutated, 6/6 DNMT3A mutated). PHF6-mutated MPAL occurred in a younger patient cohort compared with DNMT3A-mutated cases (median age, 27 years vs 61 years, P < .01). All 3 MPAL cases with both T- and B-lineage differentiation harbored PHF6 mutations. MPAL with T-lineage differentiation was associated with nodal or extramedullary involvement (9/15 [60%] vs 0, P = .001) and a higher relapse incidence (78% vs 22%, P = .017) compared with those without T-lineage differentiation. Sequencing studies on flow-cytometry-sorted populations demonstrated that PHF6 mutations are present in all blast compartments regardless of lineage differentiation with high variant allele frequency, implicating PHF6 as an early mutation in MPAL pathogenesis. In conclusion, PHF6 and DNMT3A mutations are the most common somatic alterations identified in MPAL and appear to define 2 distinct subgroups of MPAL with T-lineage differentiation with inferior outcomes.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Xiao W, Bharadwaj M, Levine M, et al. PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation. Blood Adv. 2018. PMID: 30530780. doi:10.1182/bloodadvances.2018023531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。